Loading...
You are viewing a DELETED record.
This record information is displayed for reference purpose only and should be not used.
This document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Risk Assessment generated by a regulatory process
(RA)
last updated: 13 Dec 2018
Biotechnology Consultation Memorandum of Video-Conference BNF No. 000025
EN
-
Competent National Authority:U.S. Food and Drug Administration ()DHHS/FDA/CFSAN 5100 Paint Branch ParkwayCollege Park, MD
20740, USAPhone:Fax:Email: biotechfood@fda.gov,Website:
-
CGN-89111-8 - High oleic acid canola| Monsanto (Calgene) | Production of medical or pharmaceutical compounds (human or animal) (Omega-3 fatty acids (e.g. DHA)), Resistance to antibiotics (Kanamycin)
- U.S. Food and Drug Administration [ English ]
EN
Record type | Field | Record(s) | |||||
---|---|---|---|---|---|---|---|
|